Egis Pharmaceuticals PLC

Information

Egis Pharmaceuticals PLC a leading generic pharmaceutical company operating principally in Central and Eastern Europe is active in full pharmaceutical value chain from R&D through production of APIs and drug products to sales and marketing in more than 60 countries. Egis has extensive experience in development of value-added generic molecules, efficient manufacturing processes, robust analytical methods for determination of impurities, comprehensive knowledge of organic chemical reactions and operations and strong IP support. During the past years Egis' development capabilities were significantly increased especially with the construction of a state of the art API R&D and production Centre. By recent investments Egis has built up vertically integrated HC capabilities i.e. both HP API and FP R&D along with HC production plants also for both HP API and FP products.
Exhibitor Access Type
In-person & Online
Sub-event
FDF
Country
Hungary
Organization Type
Manufacturer/Innovator
Markets Active In
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Booth Location
1A10

Offering

Offering: Products or Services
Finished Dosage FormsAPIs (Active Pharmaceutical Ingredients)
Offering: Finished Dosage
Out-licensing

Team

Log in

See all the content and easy-to-use features by logging in or registering!